(Circulation. 1999;99:1843-1850.)
© 1999 American Heart Association, Inc.
Clinical Investigation and Reports |
Correspondence to Alfred E. Buxton, MD, Cardiovascular Section, Temple University School of Medicine, 3401 North Broad St, Philadelphia, PA 19140. E-mail abuxton{at}nimbus.ocis.temple.edu
BackgroundCardiologists often use clinical variables to determine the need for electrophysiological studies to stratify patients for risk of sudden death. It is not clear whether this is rational in patients with coronary artery disease, left ventricular dysfunction, and nonsustained ventricular tachycardia.
Methods and ResultsWe analyzed the first 1721 patients
enrolled in the Multicenter UnSustained Tachycardia Trial
to determine whether clinical variables could predict which
patients would have inducible sustained monomorphic
ventricular tachycardia. The rate of
inducibility of sustained ventricular
tachycardia was significantly higher in patients with a
history of myocardial infarction and in men compared with women. There
was a progressively increased rate of inducibility with increasing
numbers of diseased coronary arteries. There was a
significantly lower rate of inducibility in patients with prior
coronary artery bypass surgery and in patients who also had
noncoronary cardiac disease. The rate of inducibility was
higher in patients of white race, patients with recent (
6 weeks)
angina, left ventricular dyskinesis, and in patients with
greater numbers of fixed thallium defects. Inducibility was more likely
in patients who had a prior myocardial infarction complicated by
congestive heart failure, ventricular
tachycardia, or fibrillation
48 hours after the onset of
infarction. Although these associations are statistically significant,
the accuracy of the clinical variables in discriminating between
patients with and those without inducible ventricular
tachycardia is only modest (receiver operator
characteristic area <0.70).
ConclusionsMultiple clinical variables are independently associated with inducible sustained ventricular tachycardia. However, they have limited utility to guide clinical decisions regarding the use of electrophysiological testing for risk stratification in this patient population.
Key Words: death, sudden electrophysiology tachyarrhythmias
This article has been cited by other articles:
![]() |
M. C. de Waard and D. J. Duncker Prior exercise improves survival, infarct healing, and left ventricular function after myocardial infarction J Appl Physiol, September 1, 2009; 107(3): 928 - 936. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Bello, D. S. Fieno, R. J. Kim, F. S. Pereles, R. Passman, G. Song, A. H. Kadish, and J. J. Goldberger Infarct morphology identifies patients with substrate for sustained ventricular tachycardia J. Am. Coll. Cardiol., April 5, 2005; 45(7): 1104 - 1108. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Lampert, C. A. McPherson, J. F. Clancy, T. L. Caulin-Glaser, L. E. Rosenfeld, and W. P. Batsford Gender differences in ventricular arrhythmia recurrence in patients with coronary artery disease and implantable cardioverter-defibrillators J. Am. Coll. Cardiol., June 16, 2004; 43(12): 2293 - 2299. [Abstract] [Full Text] [PDF] |
||||
![]() |
C Wolpert, J Kuschyk, N Aramin, S Spehl, F Streitner, T Suselbeck, B Schumacher, K K Haase, R Schimpf, and M Borggrefe Incidence and electrophysiological characteristics of spontaneous ventricular tachyarrhythmias in high risk coronary patients and prophylactic implantation of a defibrillator Heart, June 1, 2004; 90(6): 667 - 671. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. E. Buxton The Clinical Use of Implantable Cardioverter Defibrillators: Where Are We Now? Where Should We Go? Ann Intern Med, March 18, 2003; 138(6): 512 - 514. [Full Text] [PDF] |
||||
![]() |
L. A. Pires, M. H. Lehmann, A. E. Buxton, G. E. Hafley, K. L. Lee, and the Multicenter Unsustained Tachycardia Trial Inve Differences in inducibility and prognosis of in-hospital versus out-of-hospital identified nonsustained ventricular tachycardia in patients with coronary artery disease: clinical and trial design implications J. Am. Coll. Cardiol., October 1, 2001; 38(4): 1156 - 1162. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. E. Buxton, K. L. Lee, L. DiCarlo, M. R. Gold, G. S. Greer, E. N. Prystowsky, M. F. O'Toole, A. Tang, J. D. Fisher, J. Coromilas, et al. Electrophysiologic Testing to Identify Patients with Coronary Artery Disease Who Are at Risk for Sudden Death N. Engl. J. Med., June 29, 2000; 342(26): 1937 - 1945. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. E. Buxton, K. L. Lee, J. D. Fisher, M. E. Josephson, E. N. Prystowsky, G. Hafley, and The Multicenter Unsustained Tachycardia Trial Inve A Randomized Study of the Prevention of Sudden Death in Patients with Coronary Artery Disease N. Engl. J. Med., December 16, 1999; 341(25): 1882 - 1890. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1999 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |